Graft-versus-host reactions and bone-marrow transplantation
- 31 October 1991
- journal article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 3 (5), 752-757
- https://doi.org/10.1016/0952-7915(91)90108-d
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIESTransplantation, 1991
- Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins.The Journal of Experimental Medicine, 1991
- Recognition by Human V γ 9/V δ 2 T Cells of a GroEL Homolog on Daudi Burkitt's Lymphoma CellsScience, 1990
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.The Journal of Experimental Medicine, 1990
- INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemiaNature, 1987
- T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2Cellular Immunology, 1986
- The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid GeneScience, 1986